Navicixizumab Biosimilar - Anti-DLL4 Antibody - Low endotoxin, Azide free (A323599)

Navicixizumab Biosimilar - Anti-DLL4 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to DLL4.

ELISA, FACS, Functional Assay, In Vivo

Human, Cynomolgus Macaque

Human

Monoclonal

IgG2SA - Human IgG2 with S387A mutation

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 95% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

AOS6, Delta 4, delta 4 precursor, Delta ligand 4, delta ligand 4 precursor, Delta like 4, Delta like 4 homolog, Delta like 4 protein, Delta like canonical Notch ligand 4, Delta like protein 4, Delta-like 4 (Drosophila), Delta-like protein 4, Delta4, DLL 4, DLL4_HUMAN, Drosophila Delta homolog 4, hdelta2, Homeobox protein DLL-4, MGC126344, Notch ligand delta 2, Notch ligand DLL4, Notch ligand DLL4 precursor, XDLL-4